Abstract:
The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of ATP phosphoribosyltransferase, and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of ATP-PRT, and compounds and compositions that affect ATP-PRT activity.
Abstract:
The invention relates to a novel method of assaying phosphate transfer, such as that mediated by kinases or phosphatases, using fluorescence resonance energy transfer. These assays may be used, for example, for high throughput screening of enzymes having phosphate transfer activity.
Abstract:
The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of ATP phosphoribosyltransferase, and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of ATP-PRT, and compounds and compositions that affect ATP-PRT activity.
Abstract:
The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of putative flavin oxidoreductase, and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of FMNBP, and compounds and compositions that affect FMNBP activity.
Abstract:
The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of SYKKD and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of SYKKD, and compounds and compositions that affect SYK activity.
Abstract:
The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of CHK2KD and subsets thereof, including biniding ockets, methods of using the sturcture to identify and desing affecters, including inhibitors and activator, mutants of CHK2KD, CHK2KD crystals and compounds and compositions that affect CHK2 activity.
Abstract:
The present invention provides machine readable media embedded with the threedimensional molecular structure coordinates of Ab1KD and variants and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator Ab1KD crystals and compounds and compositions that affect Abl activity.
Abstract:
The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of EPHA7KD and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of EPHA7KD, EPHA7KD crystals and compounds and compositions that affect EPHA7 activity.
Abstract:
The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of BNAB protein, and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of BNAB, and compounds and compositions that affect BNAB activity.
Abstract:
The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of MST3KD and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of MST3KD, and compounds and compositions that affect MST3KD activity.